D‐cycloserine vs placebo
- The effectiveness and adverse effects of D‐cycloserine compared with placebo on social and communication skills in… 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 67 participantsLow
D‐cycloserine showed no clear difference in total adverse events compared with placebo (low certainty).
D‐cycloserine showed no clear difference in non‐core symptoms of ASD compared with placebo (low certainty).
D‐cycloserine showed no clear difference in tolerability compared with placebo (low certainty).
It is very uncertain whether standard treatment plus systemic corticosteroids changes length of hospital stay compared with standard treatment alone (very low certainty).
It is very uncertain whether standard treatment plus systemic corticosteroids changes preservation of visual acuity compared with standard treatment alone (very low certainty).
It is very uncertain whether standard treatment plus systemic corticosteroids changes severity of pain on day 3 compared with standard treatment alone (very low certainty).
It is very uncertain whether standard treatment plus systemic corticosteroids changes duration of time requiring intravenous antibiotics compared with standard treatment alone (very low certainty).
It is very uncertain whether standard treatment plus systemic corticosteroids changes need for surgical intervention compared with standard treatment alone (very low certainty).
It is very uncertain whether standard treatment plus systemic corticosteroids changes adverse effects: exposure keratopathy compared with standard treatment alone (very low certainty).
The review found no eligible studies for this question.
Comparison 1: Individual CBT‐based psychotherapy showed no clear difference in repetition of SH by post‐intervention compared with TAU or other comparator (low certainty).
Comparison 2: DBT‐A leads to lower repetition of SH at post‐intervention compared with TAU or another comparator (high certainty).
It is very uncertain whether comparison 3: MBT‐A changes repetition of SH at post‐intervention compared with TAU or another comparator (very low certainty).
Comparison 7: Family therapy showed no clear difference in repetition of SH at post‐intervention compared with placebo (moderate certainty).
Posterior reconstruction showed no clear difference in urinary continence within 1 week after catheter removal MCID: 5%… compared with no posterior reconstruction (low certainty).
Posterior reconstruction showed no clear difference in urinary continence 3 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).
Posterior reconstruction showed no clear difference in serious adverse events compared with no posterior reconstruction (moderate certainty).
Posterior reconstruction showed no clear difference in urinary continence 6 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (moderate certainty).